NEULAND LABORATORIES
Back to Cashflow Statement
|
NEULAND LABORATORIES Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹317 Cr | ₹261 Cr | ₹237 Cr | ₹60 Cr | ₹189 Cr |
What is the latest Cash Flow from Operating Activities ratio of NEULAND LABORATORIES ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2025 | ₹317 Cr |
| Mar2024 | ₹261 Cr |
| Mar2023 | ₹237 Cr |
| Mar2022 | ₹60 Cr |
| Mar2021 | ₹189 Cr |
How is Cash Flow from Operating Activities of NEULAND LABORATORIES Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹317 Cr | 21.52 | |
| Mar2024 | ₹261 Cr | 10.10 | |
| Mar2023 | ₹237 Cr | 292.81 | |
| Mar2022 | ₹60 Cr | -68.11 | |
| Mar2021 | ₹189 Cr | - | |
Compare Cash Flow from Operating Activities of peers of NEULAND LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NEULAND LABORATORIES | ₹23,145.2 Cr | 6.4% | 8.7% | 37.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹448,148.0 Cr | 2.6% | 1.2% | 13% | Stock Analytics | |
| DIVIS LABORATORIES | ₹179,009.0 Cr | 1.3% | -2.1% | 3.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹152,779.0 Cr | 1.5% | 0.7% | 37.1% | Stock Analytics | |
| CIPLA | ₹115,772.0 Cr | 6.1% | 2.4% | -5.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹108,616.0 Cr | 2.6% | -0.4% | -2.1% | Stock Analytics | |
NEULAND LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NEULAND LABORATORIES | 6.4% |
8.7% |
37.2% |
| SENSEX | -0.8% |
1.4% |
-6.8% |
You may also like the below Video Courses